When you make an impact on the future of proximity based biologics, you make a few headlines in the process. Read what others are saying about InduPro and see what we’ve published.
06/14/2024
On Thursday, a startup named InduPro, founded by three scientists from Merck — including two who invented the protein mapping technique — revealed its plans to refine the technology and design antibody drugs. InduPro, whose name is a portmanteau of “induced proximity,” has raised $85 million in Series A financing, the company told Endpoints News […]
06/13/2024
SEATTLE and CAMBRIDGE, Mass., June 13, 2024 /PRNewswire/ — InduPro, Inc., a biotechnology company defining protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimmune diseases, today announced an $85 million Series A financing co-led by The Column Group and Vida Ventures with participation from investors, including MRL Ventures Fund (the therapeutics-focused venture fund of Merck & Co, Inc.), […]
Taylor O. Hope, Tamara Reyes-Robles, Keun Ah Ryu, Steven Mauries, Nicole Removski, Jacinthe Maisonneuve, Rob C. Oslund, Olugbeminiyi O. Fadeyi and Mathieu Frenette
02/19/2024
ACS Catal. 2024, 14, 5, 3482–3491 Publication Date:February 19, 2024 https://doi.org/10.1021/acscatal.4c00447
01/08/2024
InduPro is proud to have been selected to present at #BiotechShowcase! Join us in San Francisco on Monday, January 8 at 2:30PM in the Franciscan Ballroom C to attend our presentation. Register now to meet one-to-one: biotechshowcase.com.
06/05/2023
InduPro is mapping the cell-surface proteome and designing novel binding proteins to bring cell-surface proteins together to manipulate signaling biology across a range of disease-relevant contexts.
InduPro Seattle
1930 Boren Ave Suite 200
Seattle, WA 98101
InduPro Boston
215 First Street, Suite 150
Cambridge, MA 02142
Phone
(206) 593-5005
General Inquiries:
[email protected]
